To disseminate the findings generated in VALUE-Dx by using various forms of communication and educational activities and publications at all levels of stakeholder platforms to promote their uptake and implementation in daily clinical practice and policy
To develop innovative, effective ways to disseminate information for creating awareness of optimal diagnosis and prognosis of CA-ARTI to prevent unnecessary prescription and use of antibiotics, to improve coverage with antibiotics, and thus limit antibiotic resistance and associated health and socioeconomic impacts
To develop and to tailor materials to support the adoption of CA-ARTI-Dx in European community care settings
https://www.value-dx.eu/wp-content/uploads/2023/08/shutterstock_1714915966-scaled.jpg14212560Leandrahttps://www.value-dx.eu/wp-content/uploads/2019/07/Logo-300x124.pngLeandra2023-08-03 12:43:432023-08-03 12:43:43Stakeholders’ views and experiences on implementing new diagnostics in primary care
Read our interview with Dr. Agnes Sonnevend from the Pécs University Hospital in Hungary. Dr. Sonnevend elaborates on the importance and challenges of tackling AMR, her role in this and more.
https://www.value-dx.eu/wp-content/uploads/2023/07/Agnes_Sonnevend_photo-e1689236894720.jpg515406Kristof Vanmunsterhttps://www.value-dx.eu/wp-content/uploads/2019/07/Logo-300x124.pngKristof Vanmunster2023-07-25 08:00:572023-07-25 12:52:54AMR expert interview with Dr. Agnes Sonnevend